Key regions: Australia, Brazil, United Kingdom, Europe, Canada
Burundi, a landlocked country in East Africa, has been experiencing a steady growth in the Other Vaccines market.
Customer preferences: The Burundian population has shown an increasing demand for vaccines beyond the traditional vaccines such as polio, measles, and yellow fever. The rise in the demand for Other Vaccines can be attributed to several factors such as the country's efforts to improve its healthcare system, awareness campaigns by the government, and the growing concern for infectious diseases.
Trends in the market: The Other Vaccines market in Burundi has been growing at a steady pace due to the country's efforts to improve its healthcare system. The government has been investing in healthcare infrastructure, which has led to an increase in the availability of vaccines in the country. Additionally, the government has been conducting awareness campaigns to educate the population on the importance of vaccinations, which has contributed to the rise in demand for Other Vaccines.
Local special circumstances: Burundi is one of the poorest countries in the world, and this has had an impact on the healthcare system. The country has a shortage of healthcare professionals, which has led to a reliance on international aid to support the healthcare system. Additionally, the country has been experiencing political instability, which has affected the healthcare system. The instability has led to a decrease in the availability of vaccines in some parts of the country.
Underlying macroeconomic factors: Burundi's economy is heavily dependent on agriculture, which accounts for over 90% of the country's exports. The country has been experiencing slow economic growth, which has affected the healthcare system. The government has been struggling to allocate resources to the healthcare sector, which has led to a reliance on international aid. The country's political instability has also affected the economy, which has had an impact on the healthcare system. In conclusion, the Other Vaccines market in Burundi has been growing steadily due to the country's efforts to improve its healthcare system and the growing concern for infectious diseases. However, the country's political instability and slow economic growth have had an impact on the healthcare system, which has affected the availability of vaccines in some parts of the country.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
